-
公开(公告)号:US5006330A
公开(公告)日:1991-04-09
申请号:US277708
申请日:1988-11-30
Applicant: Esther M. Sternberg , Ronald L. Wilder , George P. Chrousos , Philip W. Gold
Inventor: Esther M. Sternberg , Ronald L. Wilder , George P. Chrousos , Philip W. Gold
IPC: G01N33/74 , A61K31/40 , A61K31/495 , G01N33/50
CPC classification number: G01N33/5091 , A61K31/40 , A61K31/495 , Y10S514/825
Abstract: Inbred Lewis (LEW/N) female rats develop an arthritis in response to Group A streptococcal cell wall peptidoglycanpolysaccharide (SCW) which mimics human rheumatoid arthritis. Histocompatible Fischer (F344/N) rats, on the other hand, do not develop arthritis in response to the same SCW stimulus. To evaluate this difference in inflammatory reactivity between the two strains, the function of the hypothalamic-pituitary-adrenal axis and its ability to modulate the development of the inflammatory response was studied. It has been found that, in contrast to F344/N rats, LEW/N rats had markedly impaired plasma ACTH and corticosterone responses to SCW, recombinant human Interleukin-1 alpha (IL-1 alpha), the serotonin agonist, quipazine, and synthetic rat corticotropin-releasing hormone (CRH). In addition, LEW/N rats compared to F344/N rats had smaller adrenal glands and larger thymuses. Treatment of LEW/N rats with replacement doses of dexamethasone decreased the severity of their SCW-induced arthritis. Conversely, treatment of F344/N rats with the glucocorticoid receptor antagonist, RU 486, or the serotonin (5-HT.sub.2) antagonist, LY53857, was associated with development of severe inflammatory disease, including arthritis, in response to SCW. These findings support the concept that susceptibility of LEW/N rats to SCW arthritis is related to abnormal hypothalamic-pituitary-adrenal (HPA) axis responsiveness to inflammatory and other stress mediators and that resistance of F344/N rats to SCW arthritis is regulated by an intact HPA axis-immune system feedback loop.
Abstract translation: 近交路易斯(LEW / N)雌性大鼠针对模拟人类类风湿关节炎的A组链球菌细胞壁肽聚糖多糖(SCW)产生关节炎。 另一方面,组织相容性Fischer(F344 / N)大鼠不会对相同的SCW刺激产生关节炎。 为了评估两种菌株之间的炎症反应性差异,研究了下丘脑 - 垂体 - 肾上腺轴的功能及其调节炎症反应发展的能力。 已经发现,与F344 / N大鼠相比,LEW / N大鼠对SCW,重组人白细胞介素-1α(IL-1α),血清素激动剂,喹地平和合成的血浆ACTH和皮质酮反应明显受损 大鼠促肾上腺皮质激素释放激素(CRH)。 此外,与F344 / N大鼠相比,LEW / N大鼠具有较小的肾上腺和较大的胸腺。 用替代剂量的地塞米松治疗LEW / N大鼠降低其SCW诱导的关节炎的严重程度。 相反,用糖皮质激素受体拮抗剂RU 486或5-羟色胺(5-HT2)拮抗剂LY53857处理F344 / N大鼠与SCW相关的严重炎症性疾病(包括关节炎)的发展有关。 这些发现支持LEW / N大鼠对SCW关节炎的易感性与异常的下丘脑 - 垂体 - 肾上腺(HPA)轴对炎症和其他应激介质的反应性有关的概念,F344 / N大鼠对SCW关节炎的抵抗力由 完整的HPA轴免疫系统反馈回路。
-
公开(公告)号:US5348729A
公开(公告)日:1994-09-20
申请号:US878608
申请日:1992-05-05
Applicant: Esther M. Sternberg , Philip W. Gold , Samuel W. Page
Inventor: Esther M. Sternberg , Philip W. Gold , Samuel W. Page
IPC: A61K31/135 , A61K31/35 , A61K31/365 , A61K31/40 , A61K31/485 , A61K31/495 , A61K31/565 , A61K31/57 , A61K31/585 , A61K38/22 , A61K45/06 , G01N33/50 , G01N33/564 , G01N33/74 , G01N1/00 , A61K37/60 , A61K45/05 , G01N33/48
CPC classification number: A61K31/40 , A61K31/135 , A61K31/35 , A61K31/365 , A61K31/485 , A61K31/495 , A61K31/565 , A61K31/57 , A61K31/585 , A61K45/06 , G01N33/5091 , G01N33/564 , G01N33/74 , G01N33/743 , G01N2800/102 , Y10S435/975 , Y10S514/805 , Y10S514/825 , Y10S514/885 , Y10S514/886
Abstract: The present invention is directed to a method for testing the susceptibility of a mammal to inflammatory diseases which comprises the steps of:administering to a mammal a compound selected from the group consisting of Type 1 mineralocorticoid receptor antagonists, opiate antagonists, estrogen antagonists or mixed estrogen agonists/antagonists, progesterone agonists; or a combination of an estrogen antagonist with one or a combination of a Type I glucocorticoid receptor antagonist, a Type II glucocorticoid agonist or a progesterone agonist which is effective in stimulating the hypothalamic-pituitary-adrenal (HPA) axis; andmeasuring the level of at least one hormone secreted by the hypothalamus, pituitary or adrenal glands of said mammal.The present invention is also directed to methods of treating inflammatory diseases.
Abstract translation: 本发明涉及一种用于测试哺乳动物对炎性疾病的敏感性的方法,其包括以下步骤:向哺乳动物施用选自1型盐皮质激素受体拮抗剂,阿片剂拮抗剂,雌激素拮抗剂或混合雌激素 激动剂/拮抗剂,孕酮激动剂; 或雌激素拮抗剂与有效刺激下丘脑 - 垂体 - 肾上腺(HPA)轴的I型糖皮质激素受体拮抗剂,II型糖皮质激素激动剂或孕酮激动剂的组合的组合。 并测量由所述哺乳动物的下丘脑,垂体或肾上腺分泌的至少一种激素的水平。 本发明还涉及治疗炎性疾病的方法。
-
公开(公告)号:US5209920A
公开(公告)日:1993-05-11
申请号:US412294
申请日:1989-09-25
Applicant: Esther M. Sternberg , Ronald L. Wilder , Philip W. Gold , George P. Chrousos
Inventor: Esther M. Sternberg , Ronald L. Wilder , Philip W. Gold , George P. Chrousos
IPC: A61K31/135 , A61K31/35 , A61K31/365 , A61K31/40 , A61K31/485 , A61K31/495 , A61K31/565 , A61K31/57 , A61K31/585 , A61K38/22 , A61K45/06 , G01N33/50 , G01N33/564 , G01N33/74
CPC classification number: A61K31/135 , A61K31/35 , A61K31/365 , A61K31/40 , A61K31/485 , A61K31/495 , A61K31/565 , A61K31/57 , A61K31/585 , A61K38/11 , A61K38/2228 , A61K45/06 , G01N33/5091 , G01N33/564 , G01N33/74 , G01N33/743 , G01N2800/102 , Y10S435/975 , Y10S514/805 , Y10S514/825 , Y10S514/885 , Y10S514/886 , Y10S514/889
Abstract: Inbred Lewis (LEW/N) female rats develop an arthritis in response to Group A streptococcal cell wall peptidoglycanpolysaccharide (SCW) which mimics human rheumatoid arthritis. Histocompatible Fischer (F344/N) rats, on the other hand, do not develop arthritis in response to the same SCW stimulus. To evaluate this difference in inflammatory reactivity between the two strains, the function of the hypothalamic-pituitary-adrenal axis and its ability to modulate the development of the inflammatory response was studied. It has been found that, in contrast to F344/N rats, LEW/N rats had markedly impaired plasma ACTH and corticosterone responses to SCW, recombinant human Interleukin-1 alpha (IL-1 alpha), the serotonin agonist, quipazine, and synthetic rat corticotropin-releasing hormone (CRH). In addition, LEW/N rats compared to F344/N rats had smaller adrenal glands and larger thymuses. Treatment of LEW/N rats with replacement doses of dexamethasone decreased the severity of their SCW-induced arthritis. Conversely, treatment of F344/N rats with the glucocorticoid receptor antagonist, RU 486, or the serotonin (5-HT.sub.2) antagonist, LY53857, was associated with development of severe inflammatory disease, including arthritis, in response to SCW. These findings support the concept that susceptibility of LEW/N rats to SCW arthritis is related to abnormal hypothalamic-pituitary-adrenal (HPA) axis responsiveness to inflammatory and other stress mediators and that resistance of F344/N rats to SCW arthritis is regulated by an intact HPA axis-immune system feedback loop.
Abstract translation: 近交路易斯(LEW / N)雌性大鼠针对模拟人类类风湿关节炎的A组链球菌细胞壁肽聚糖多糖(SCW)产生关节炎。 另一方面,组织相容性Fischer(F344 / N)大鼠不会对相同的SCW刺激产生关节炎。 为了评估两种菌株之间的炎症反应性差异,研究了下丘脑 - 垂体 - 肾上腺轴的功能及其调节炎症反应发展的能力。 已经发现,与F344 / N大鼠相比,LEW / N大鼠对SCW,重组人白细胞介素-1α(IL-1α),血清素激动剂,喹地平和合成的血浆ACTH和皮质酮反应明显受损 大鼠促肾上腺皮质激素释放激素(CRH)。 此外,与F344 / N大鼠相比,LEW / N大鼠具有较小的肾上腺和较大的胸腺。 用替代剂量的地塞米松治疗LEW / N大鼠降低其SCW诱导的关节炎的严重程度。 相反,用糖皮质激素受体拮抗剂RU 486或5-羟色胺(5-HT2)拮抗剂LY53857处理F344 / N大鼠与SCW相关的严重炎症性疾病(包括关节炎)的发展有关。 这些发现支持LEW / N大鼠对SCW关节炎的易感性与异常的下丘脑 - 垂体 - 肾上腺(HPA)轴对炎症和其他应激介质的反应性有关的概念,F344 / N大鼠对SCW关节炎的抵抗力由 完整的HPA轴免疫系统反馈回路。
-
-